Co-Innovation Biotech
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A collaborative biotech firm discovering novel drugs for cancer, neurological, and metabolic disorders.
OncologyNeuroscienceMetabolic
Technology Platform
A flexible, biology-first collaborative platform that identifies and validates novel targets from external research, translating them into drug candidates across multiple modalities.
Opportunities
Potential to secure lucrative partnership deals with large pharma for its novel, early-stage assets.
Risk Factors
High attrition rate of early-stage projects and reliance on the continuity of external collaborations.
Competitive Landscape
Competes in the high-risk, high-reward space of novel target discovery against numerous other small biotechs and academic spin-offs.